METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

GeroScience, published by Springer, is an esteemed open-access journal that focuses on the multidisciplinary field of aging research. Since its inception in 2017, the journal has quickly established itself as a leader in its field, achieving impressive Q1 quartile rankings across various categories, including Aging, Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, and Complementary and Alternative Medicine, as per 2023 evaluations. With a significant impact factor that underscores its influence and reach in academia, GeroScience aims to disseminate high-quality research that addresses the complex challenges and advancements related to aging. Its accessible publication format fosters greater dissemination of knowledge and encourages collaboration among researchers, practitioners, and students eager to contribute to the growing body of work on age-related health issues. As it continues to thrive, GeroScience remains a pivotal resource for anyone looking to stay at the forefront of aging research.

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.

CHINESE JOURNAL OF PHYSIOLOGY, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, has been a vital resource since its inception in 1971, catering to the expansive field of physiology. Operating out of Taiwan, this journal addresses critical research in both general and medical physiology, providing a platform for innovative studies that contribute significantly to the understanding of biological processes. With an emphasis on disseminating high-quality, peer-reviewed articles, it holds a Q4 ranking in Physiology and a Q3 ranking in Medical Physiology as of 2023, reflecting its commitment to advancing physiological science. The ISSN for this journal is 0304-4920 and the E-ISSN is 2666-0059. While access options are not available as open access, researchers and professionals can still benefit from its valuable insights. Notably, it ranks #78/113 in Medicine - Physiology and #159/193 in Biochemistry, Genetics, and Molecular Biology - Physiology on Scopus, indicating its growing influence in the scientific community. We invite researchers, professionals, and students alike to explore the wealth of knowledge featured within the pages of the CHINESE JOURNAL OF PHYSIOLOGY.

Discovery Medicine, an esteemed journal published by Discovery Medicine, serves as a vital platform within the field of general medicine, dedicated to advancing knowledge through high-quality research and innovative insights. With its ISSN 1539-6509 and E-ISSN 1944-7930, this journal boasts an impressive Scopus ranking of #29 out of 529 in the general medicine category, positioning it at the 94th percentile, indicating its significant contribution to the medical sciences. While operating as a subscription-based journal, Discovery Medicine fosters an environment where researchers and professionals can disseminate their findings and engage with cutting-edge developments in medicine. Spanning topics that bridge clinical practice and healthcare advancements, this journal aims to inform, challenge, and inspire the medical community. The journal has converged its volumes from 2006 to 2007 and again from 2009 to 2018, highlighting its sustained commitment to excellence even as coverage has temporarily discontinued in Scopus. Situated at 10 Gerard Ave, Ste 201, Timonium, MD 21093, Discovery Medicine continues to be a cornerstone for medical scholars, offering a rich repository of knowledge essential for ongoing research and practical applications.

STRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

Acta Physiologica is a premier, peer-reviewed journal published by WILEY, dedicated to the dissemination of high-quality research across the field of physiology. With an impressive impact factor reflective of its Q1 category ranking in Physiology for 2023, this journal is a vital resource for researchers, professionals, and students alike, seeking to explore the complexities of biological systems. The journal is indexed with a commendable Scopus rank of #18 out of 193 in its category, placing it within the top 10% of its field, which underscores its influence and citation frequency within the academic community. Acta Physiologica publishes a variety of articles that address fundamental physiological concepts, innovative methodologies, and cross-disciplinary research. With its open access options, the journal ensures that cutting-edge knowledge is readily accessible, fostering an environment of collaboration and advancement in the study of physiology. Spanning from 2006 to 2024, the journal continues to be at the forefront of physiological research and education, encouraging the global sharing of knowledge through its comprehensive content.

The Journal of Physiological Sciences, published by BMC, stands as a prominent platform for the advancement of research in the field of physiology. Based in Japan, this open-access journal (ISSN: 1880-6546, E-ISSN: 1880-6562) is committed to disseminating high-quality scientific articles that explore various facets of physiological functions and mechanisms. With a 2023 Scopus ranking placing it within the 41st percentile in the category of Physiology, it is recognized for contributing significant insights that bridge basic and applied physiological research. The journal maintains a Q2 quartile ranking within its category, highlighting its impact within the scientific community. Researchers, professionals, and students are encouraged to engage with cutting-edge studies published from 2006 to 2024, fostering an environment of knowledge accessibility and scientific collaboration. The journal not only serves as a vital resource for those involved in physiological research but also promotes broader understanding and application of physiological principles across various health and science sectors.